Dimensional Fund Advisors LP Has Decreased Its Position in Pfizer INC (PFE) by $43.72 Million

March 23, 2018 - By Nellie Frank

Investors sentiment increased to 0.96 in 2017 Q3. Its up 0.02, from 0.94 in 2017Q2. It is positive, as 53 investors sold PFE shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. Charter Trust invested in 273,121 shares. Perkins Capital Mngmt holds 1.94% or 51,934 shares. 2.06 million are owned by Ing Groep Nv. Westwood Holding Grp Incorporated has invested 0.01% in Pfizer Inc. (NYSE:PFE). 608,940 were reported by Dana Invest Advsr Inc. Baker Ellis Asset Mngmt Lc holds 40,143 shares or 0.38% of its portfolio. Jacobs & Ca owns 200,911 shares for 1.35% of their portfolio. 8,003 were accumulated by Tortoise Investment Limited Liability. Madison Hldg reported 640,808 shares or 0.41% of all its holdings. Stephens Ar accumulated 404,778 shares. Sonata Capital Group invested in 20,582 shares or 0.55% of the stock. Moreover, Howe & Rusling Incorporated has 2.43% invested in Pfizer Inc. (NYSE:PFE) for 367,452 shares. Notis has invested 0.35% of its portfolio in Pfizer Inc. (NYSE:PFE). Broderick Brian C has 0.25% invested in Pfizer Inc. (NYSE:PFE). Tiedemann Wealth Mngmt Limited Liability Corporation reported 0.3% of its portfolio in Pfizer Inc. (NYSE:PFE).

Since December 15, 2017, it had 0 insider purchases, and 12 selling transactions for $12.99 million activity. Another trade for 27,323 shares valued at $998,666 was made by JOHNSON RADY A on Tuesday, March 13. The insider Dolsten Mikael sold 64,587 shares worth $2.39 million. LANKLER DOUGLAS M had sold 50,000 shares worth $1.84 million. Shares for $249,750 were sold by MACKENZIE ALEXANDER R. $986,292 worth of Pfizer Inc. (NYSE:PFE) was sold by HILL CHARLES H. LUND-JURGENSEN KIRSTEN sold $353,677 worth of Pfizer Inc. (NYSE:PFE) on Saturday, February 24.

Dimensional Fund Advisors Lp decreased its stake in Pfizer Inc (PFE) by 2.82% based on its latest 2017Q3 regulatory filing with the SEC. Dimensional Fund Advisors Lp sold 1.25M shares as the company’s stock declined 3.45% while stock markets rallied. The institutional investor held 43.04 million shares of the health care company at the end of 2017Q3, valued at $1.54 billion, down from 44.29M at the end of the previous reported quarter. Dimensional Fund Advisors Lp who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $211.77 billion market cap company. The stock decreased 1.85% or $0.67 during the last trading session, reaching $35.6. About 20.96M shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since March 23, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

Dimensional Fund Advisors Lp, which manages about $228.83 billion US Long portfolio, upped its stake in Wesco Intl Inc (NYSE:WCC) by 170,919 shares to 3.93 million shares, valued at $228.66M in 2017Q3, according to the filing. It also increased its holding in Lear Corp (NYSE:LEA) by 42,464 shares in the quarter, for a total of 933,481 shares, and has risen its stake in Danaher Corp Del (NYSE:DHR).

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on May, 1. They expect $0.73 earnings per share, up 5.80 % or $0.04 from last year’s $0.69 per share. PFE’s profit will be $4.34B for 12.19 P/E if the $0.73 EPS becomes a reality. After $0.62 actual earnings per share reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts 17.74 % EPS growth.

Pfizer Inc. (NYSE:PFE) Ratings Coverage

Among 22 analysts covering Pfizer (NYSE:PFE), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pfizer has $54.0 highest and $33.0 lowest target. $39.80’s average target is 11.80% above currents $35.6 stock price. Pfizer had 75 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with “Buy” on Monday, June 20. The stock has “Hold” rating by SunTrust on Sunday, January 28. Leerink Swann maintained the shares of PFE in report on Monday, May 2 with “Market Perform” rating. Jefferies maintained Pfizer Inc. (NYSE:PFE) rating on Thursday, April 7. Jefferies has “Buy” rating and $39 target. The stock of Pfizer Inc. (NYSE:PFE) has “Sell” rating given on Tuesday, May 16 by Citigroup. The rating was maintained by Piper Jaffray on Wednesday, August 2 with “Buy”. The rating was upgraded by SunTrust to “Neutral” on Wednesday, November 25. The stock of Pfizer Inc. (NYSE:PFE) has “Market Perform” rating given on Wednesday, November 2 by BMO Capital Markets. The rating was maintained by Jefferies with “Buy” on Thursday, July 14. The stock of Pfizer Inc. (NYSE:PFE) has “Equal-Weight” rating given on Tuesday, December 1 by Barclays Capital.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.